Vincerx Pharma, Inc.
VINC
$0.8145
$0.00550.68%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 12.92% | 84.35% | 15.16% | 56.04% | 46.64% |
| Total Depreciation and Amortization | 8.27% | 8.43% | 71.43% | 7.05% | 7.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 286.79% | -525.34% | 457.05% | 146.22% | -81.66% |
| Change in Net Operating Assets | -126.78% | 105.14% | -448.27% | -119.31% | 411.28% |
| Cash from Operations | 4.00% | 54.10% | 40.89% | 41.96% | 55.32% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -90.88% | -156.32% | -- | 128.21% | 174.58% |
| Cash from Investing | -90.88% | -156.32% | -- | 128.21% | 174.58% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 18,181.72% | 66.67% | -52.63% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 18,181.72% | 66.67% | -52.63% | -- |
| Foreign Exchange rate Adjustments | 258.82% | -140.00% | 140.00% | -259.26% | -213.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -159.27% | 28.45% | -6.80% | 93.28% | 123.96% |
